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ABSTRACT 
This experiment was designed to determine the involvement of varying levels of 
whole-body irradiation on ovarian follicular and corpora luteal development in mice. 
Previous research has indicated reduced counts of ovarian follicles and corpora lutea in 
mice flown in space. These differences may be the result of microgravity, increased 
exposure to radiation, or some combination of both. Fifty-six mice were divided into 
three groups (apocynin-treated, nox2 knockout, and wild-type control) before exposure to 
0 Gy, 0.5 Gy, or 2.0 Gy radiation. The tissues were harvested, preserved, run through the 
appropriate paraffin embedding procedures, serially sectioned, mounted on microscope 
slides, and stained using a standard H&E staining technique. Total and mean follicular 
and corpora luteal counts were accessed and compared across treatment groups. Mean 
ovarian weight, mean total reproductive weight, mean ovarian weight percentage of total 
body weight, mean total reproductive weight percentage of total body weight, and the 
apparent estrous phase of the animals were also compared. Radiation from 0.5-2.0 Gy 
had no significant effect on mean ovarian weight, mean total reproductive weight, mean 
ovarian weight percentage of total body weight, or mean total reproductive weight 
percentage of total body weight. Radiation from 0.5-2.0 Gy significantly increased mean 
early-stage follicular count in the wildtype group only. Radiation of 2.0 Gy increased 
late-stage follicular count across all groups after accounting for mean ovarian percent of 
total body weight. Radiation of 2.0 Gy significantly increased mean corpora lutea count 
in the wildtype group only. This result not only suggests that low-dose radiation 
accelerates oocyte development in the murine ovary, but also that the inaction of 
NADPH-oxidase (via apocynin inhibition or genetic knockout) may ameliorate some of 
these effects. 
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INTRODUCTION 
Throughout its history on planet Earth, mankind has expanded its habitat to 
include the most extreme of environs, facing dramatic changes in temperature, 
molecular oxygen level, and illumination. Now man looks to conquer a new habitat, 
Mars and the space between, and the journey threatens to expose astronauts to the 
full spectrum of gravitational force. The challenges on Mars itself will resemble 
those most unforgiving habitats of Earth. Its surface is frozen, hypoxic, and 
unprotected from solar radiation. Investigation into such extreme conditions, and 
their combined effect upon human physiology, must be understood if spaceflight is 
to be a viable option for prolonging and protecting man’s future.  
The Space Studies Board and National Research Council convened in 1991 to 
address research goals for the new millennium, highlighting a need for spaceflight 
experimentation in the area of human viability in space. Possible reproductive 
pathologies associated with orbit were a primary concern. And although the 
recommendation by the council that spaceflight test animals remain in orbit for 2 
life cycles has been largely abandoned in favor of cheaper, shorter experiments, the 
ongoing mission of the National Aeronautics and Space Agency (NASA) to increase 
spaceflight funding has been a successful one. Such progress is illustrated by the 
wealth of experiments that have been and are being done upon the recently 
constructed International Space Station (ISS). ISS is outfitted specifically for 
developmental biological studies. Organized by Professor Sally A. Moody of George 
Washington University and Dr. Catherine Golden of NASA, the International Space 
Life Sciences Working Group Developmental Biology Workshop aimed to further 
spaceflight research, specifically in reference to the processes of gametogenesis, 
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fertilization, organogenesis, and vestibular system development (Moody and 
Golden, 2000).  
These findings were revisited inside the 2011 Decadal Survey on Biological 
and Physical Sciences in Space, which proposed a research effort to examine the 
efficacy of spaceflight-induced bone loss countermeasures, such as exercise and 
anti-osteoporosis drugs. The survey emphasizes current questions concerning the 
health of female astronauts, particularly the physiological impact of interrupting the 
menstrual cycle during spaceflight, a common practice for NASA employees 
(National Research Council Decadal Survey, 2011).  
As Droppert (1990) suggests, the first country to resolve the deleterious 
effects of spaceflight will be well on its way to colonizing Mars. Chapes et al. (1993) 
illustrated a pronounced need for more experimentation in the area of orbit’s effect 
on immune tissue, prompting work on the action of inflammatory neutrophils, 
activated macrophages, and cytokines in space.  In 1992, NASA itself expressed a 
need for an increased biological research endeavor in space (Motabagani, 1992).  
 
Effect of Spaceflight on Various Organ Systems 
Space-related research includes data on the musculoskeletal system 
(Dropper, 1990; Ferguson et al., 2002; Meigal, 2012; Milstead et al., 2004; Sandona 
et al., 2012; Stabley, 2012), the cardiovascular system (Agarwal, 2010; Dabertrand 
et al., 2012; Zuj et al., 2012), the lymphatic system (Armstrong et al., 1993; Chapes et 
al., 1993; Chapes et al., 1999), the urinary system (Kaplanskii et al., 2008), the 
nervous system (Frigeri et al., 2008; Santucci et al., 2012), and the digestive system 
(Atlashkin et al., 2012). 
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Droppert (1990) reported a decreased calcium concentration in the weight-
bearing bones of astronauts in orbit. Increased exercise, drugs involved in calcium 
storage and reuptake, high-calcium diets, and artificial gravity technologies have 
been used to ameliorate calcium decrease with some success. These findings are 
important because such calcium loss could increase the possibility of bone fractures 
or premature osteoporosis in astronauts returning to Earth. 
 Sadona et al. (2012) investigated the effects of long-term low-gravity 
exposure on skeletal muscle in mice. In their experiments, mice were subjected to 
91 days of orbit on the ISS. The study revealed greater slow-twitch atrophy and 
alteration of gene expression in both the soleus and extensor digitorum longus 
muscles, though the effect was enhanced in the soleus. This data suggests that the 
extensor digitorum longus muscle may have compensatory mechanisms that allow 
some level of resistance to microgravity (Sadona et al., 2012).  
Stabley et al. (2012) concluded that although arterial vessel wall thickness 
and diameter remained unchanged, orbit reduced voltage-gated calcium and 
norepinephrine vasocontrictor responses, linked to low ryanodine receptor 
subtype-2 and subtype-3 expression in spaceflight subjects. These receptors 
facilitate calcium release deep within smooth muscular tissue. This calcium binds to 
filamentous troponin, shifting the tropopin-tropomyosin complex and revealing 
binding sites on actin proteins to the globular heads of myosin, resulting in 
muscular contraction (Widmaier et al., 2011). As a result, the researchers found that 
smooth muscle contractility was inhibited in mice exposed to spaceflight (Stabley et 
al., 2012). 
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Natural systolic blood pressure variation, maintained by circadian rhythms 
over a 24-hour period, was shown to be disrupted by spaceflight (Agarwal, 2000). 
Blood pressure is regulated by the combined action of the suprachiasmic nucleus of 
the hypothalamus and peripheral vascular and nephritic organs. Spaceflights of 
varying lengths were shown to inhibit blood pressure regulation in both humans 
and mice . Whether this effect was the result of physical inactivity, whole-body fluid 
shifts, vasoconstriction, or a stress response while in space is unknown. Such “out-
of-phase” and “phase-less” circadian activity may result in overall organ damage, 
cardiovascular trauma, chronic kidney disease, sleep apnea, or metabolic stress 
(Agarwal, 2000). 
Santucci et al. (2012) noted 28 up-regulated proteins important to 
mitochondrial metabolism, ATP synthesis and hydrolysis, calcium and calmodin 
metabolism, the nervous system, and amino acid transport following three months 
of spaceflight. Down-regulation of some proteins involved in mitochondrial 
metabolism were also observed, along with a decrease in nerve growth factor in the 
hippocampal, cortical, and adrenal regions of the brain. 
While studying the effects of spaceflight on the digestive system, Atiashkin et 
al. (2012) compared the jejunum wall intersticium of three groups of Mongolian 
gerbils: one group orbited for 12 days upon spacecraft Foton-M3, another exposed 
to 12 days of simulated orbital factors (excluding microgravity and cosmic 
radiation), and a ground control. Damage to the internal elastic membrane of 
submucosal vessels was observed in both the flight and simulated flight groups 
compared to the control. Such damage was diluted in the simulated flight group. 
Kaplanskii et al. (2008) also comments on the unique susceptibility of the Mongolian 
 Poole 8 
gerbil to the stressful conditions of spaceflight. The animal is characterized by its 
large adrenal glands, an important site of stress-associated hormone secretion, 
including the release of epinephrine, norepinephrine, and cortisol. Mongolian 
gerbils also have a highly sensitive thymus and spleen, organs strongly influenced 
by corticosteroids (Kaplanskii et al., 2008). 
 
Effects of Spaceflight on Non-Mammalian Reproductive Tissues 
Many articles present reproductive data from non-mammalian species. Ijiri 
(1998) exposed 4 Oryzias latipes fish to 15 days of spaceflight on International 
Microgravity Laboratory 2. These small fish were the first vertebrates to 
successfully conceive in orbit, producing 8 “space-born” fry. All parameters 
examined in this study (gonadal germ cell concentration, genital ridge migration, 
and fertility) were found to be within normal limits, and insignificantly affected by 
spaceflight in comparison with ground controls.  
During an observation of the effects of simulated microgravity on ovarian 
development, Skrobanek et al. (2008) described low ovarian weight, shorter 
oviducts, delayed egg-laying, and decreased plasma progesterone in space-flown 
Japanese quails, though this did not significantly affect normal development. Souza 
et al. (1995) showed that although Xenopus laevis amphibian embryos (fertilized in 
vitro) failed to undergo rotation to align the animal-vegetal pole with Earth’s 
gravitational field, normal development was unimpeded by spaceflight. Wong and 
Desantis (1997) observed eye opening and walking in rat pups gestated aboard STS-
66, Atlantis. These events occurred within a natural time frame, although perinatal 
morbidity was higher for spaceflight subjects. 
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Effects of Spaceflight on the Reproductive Tissues of Pregnant Mammals 
Spaceflight studies focusing on mammalian reproduction have largely been 
limited to pregnant specimens. Burden et al. (1998) observed no significant 
difference between ground control mice and mice in orbit from days 11-20 of 
gestation in terms of fetal mass at day 20 of gestation, as well as myometrium 
smooth muscle volume at day 20 of gestation and postpartum. However, pup mass 
at birth (day 22-23) was significantly decreased in spaceflight mice, and uterine 
smooth muscle volume between day 20 of gestation and postpartum was decreased 
by 37% in spaceflight specimens. 
 Burden et al. (1999) showed a marked decrease in the expression of 
connexin 43, an integral protein building block in myometrial gap junctions, in mice 
exposed to spaceflight between days 11-20 of gestation. Gap junctions are important 
to the formation of a functional syncytium and electrical coupling between smooth 
muscle cells during uterine contraction. Due to this deficiency, the flight animals 
showed significantly more, though less efficacious, labor contractions at term (day 
22-23) than controls. 
 The only study to examine pregnant mammals in microgravity prior to Ronca 
and Alberts (2000) did not observe parturition, a pattern of physiological behaviors 
that include labor, delivery, maternal care, placentophagia, and nursing. Parturition 
begins with weak, nonregular uterine contractions a few hours before birth. It has 
been noted that whole-body fluid shifts, calcium loss, and muscle atrophy of the 
transverse abdominis pose a particular risk to labor. Abdominal muscles play an 
important supplementary role in expulsion of the fetus. Ronca and Alberts (2000) 
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exposed female Norway rats to either 9 or 11 days of spaceflight beginning at either 
day 11 or 9 or gestation, respectively. The rats were allowed to come to term 2-3 
days after return to a 1 G environment and monitored with time-lapse videography. 
Doubled amounts of termed “lordosis” contractions were observed in flight animals 
compared to ground controls. Lordosis contractions characterize the earliest 
contraction period during labor. The animal lies prone, arching her back and lifting 
her hindlimbs. These contractile episodes are spaced with longer rest intervals than 
vertical contractions (which occur more frequently and characterize the latter 
portion of labor) and are believed to facilitate movement of the fetus to the lower 
birth canal (Ronca and Alberts, 2000). 
 
Effects of Spaceflight on The Reproductive System of Non-Pregnant Mammals 
Only a small number of recent studies have examined non-pregnant 
mammalian reproductive tissues in a spaceflight environment, and some of these 
findings have been contradictory. Evaluation of ovaries from mice flown on shuttle 
mission STS-118 in 2007 indicated no gross morphological changes with regard to 
follicle counts and numbers of corpora lutea between spaceflight and control 
animals (Smith and Forsman, 2012). However, other reproductive tissues from the 
same animals did exhibit changes. The spaceflight environment was shown to cause 
a significant thickening of the apical mucin layer of the uterus (Nier and Forsman, 
2011, 2013). Evaluation of the apical mucin layer of the three regions of the uterine 
tube (Svalina and Forsman, 2013) indicated a trend toward a thinning of the mucin 
layer in all three regions. Measurements of the thickness of the apical mucin layer of 
the vagina indicated a significant thickening of the vaginal mucin layer in the mice 
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subjected to spaceflight (Romer, et al, 2013). These results from the last two studies 
were very interesting because in both studies there was a change, although not 
statistically significant, in the mucin layer between animals kept in normal cages 
under normal laboratory animal conditions and animals kept in the same type of 
cages used for spaceflight but kept in normal gravity conditions. This implies that 
the cage environment has an effect on the animals and that some aspect of 
spaceflight enhances this effect. 
In studies of the ovarian tissue from mice flown on shuttle mission STS-131, 
Gupta et al. (2010) and Tash et al. (2011) reported significant suppression of 
ovarian, luteal, and uteral development relative to baseline and ground control 
animals. In contrast to the findings of Smith and Forsman (2012), Tash and Gupta 
reported that examination of spaceflight ovaries indicated fewer corpora lutea and a 
large number of atretic follicles compared to control animals. They also reported a 
complete absence of corpora lutea in the spaceflight animals. They also reported 
that uterine horns harvested from spaceflight animals were also generally smaller 
than concomitant controls, although uterine gland counts were not significantly 
affected. Estrogen receptor, lactoferrin mRNA, and progesterone receptor 
expression were also found to be blunted in uteri and ovaries from spaceflight 
animals. The researchers concluded that spaceflight significantly disrupts the 
mammalian estrous cycle.  
Although changes have been reported in various locations and in various 
forms within the female reproductive system from mice subjected to spaceflight, the 
causative factor is unknown. There are two main areas that distinguish the 
spaceflight environment from the environment on Earth. The first is the 
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microgravity experienced during spaceflight and the second is the high exposure to 
radiation associated with spaceflight. 
 
Effects of Radiation on The Reproductive System of Mammals 
While many studies have shown that spaceflight has effects on various 
systems of the body, it is not known if such effects are due to the exposure of 
microgravity. Several scientists believe that cosmic radiation may be responsible for 
the various documented effects. This is because astronauts are exposed to much 
more radiation in space than on Earth (Horneck et al., 2010). In addition, cosmic 
radiation in space is characterized by the increased presence of damaging high-
energy heavy ions. The difference comes down to Earth’s atmosphere, which 
contains ultraviolet (UV) radiation absorbing ozone gas, which protects Earth’s 
inhabitants from much of the Sun’s harmful UV radiation. The same protection is not 
afforded to astronauts and test subjects on shuttle or ISS deployments, which 
explains the increase in radiation exposure. Such findings have led many 
researchers to investigate the role of radiation in human and mammalian 
reproduction, comparing these effects to those observed in space (Horneck et al., 
2010). 
The mammalian ovary is a most fascinating organ, and has been a focal point 
of both whole-body and targeted radiotherapy for over a century. The structure and 
function of the ovary are innately linked. As follicular count decreases, the organ 
becomes less likely to ovulate viable eggs. Like humans, mice cannot produce new 
oocytes after birth, and quickly lose the majority of them in early life, and the 
remaining are lost steadily throughout their life cycle. As Lindop (1969) claims, only 
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a small amount of oocytes will ovulate during the reproductive lifespan, about 100 
of 10,000 in mice, and 400 of 2 million in humans. 
The majority of radiation research on mammals has followed either whole-
body or targeted 250 kV X-rays and neutron exposure. The effect of irradiation on 
the ovary is well-documented, causing increased oocyte depletion rates, 
acceleration of oocyte maturity, reduced litter size, ovarian tumors, and various 
genetic damage. The timing of exposure, in terms of the age of the animal, is the 
most important factor in accessing the damage. An acute peak of sensitivity to 20 or 
25 rads has been reported in mice at two and a half weeks old  (Peters, 1961; 
Oakberg, 1962). One rad, the unit of ionic radiation absorbance, is equivalent to 0.01 
Gy, or 0.01 joules of absorbed radiation for every kilogram of biomaterial 
(International Bureau of Weight and Measures, 2008). Mice with nitrogen-induced 
hypoxia show a unique resistance to low-dose radiation, possibly related to a 
decrease in cellular respiratory function seen in as little as 2 minutes after exposure 
to 200 rads (Peters, 1961; Oakberg, 1962). 
However, the evidenced cell depletion may not tell the entire story of the 
ovary, and morphology may not be as closely linked to function as once thought. If 
radiative treatment is applied in early life, where the cell depletion rate is already 
highest, induced cell killing may be ameliorated by a decrease in natural cell 
depletion. Indeed, irradiated mice are more efficient at making use of the remaining 
oocyte population than control animals. Irradiated animals lost reproductive 
capability at 3-4% remaining oocyte population, while control animals lost virility at 
37% oocyte population (Lindop, 1969). 
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Lindop (1969) also comments that interspecies extrapolation between mice 
and human females is justified, though damage may present in various forms. This 
hypothesis was reiterated in the NASA’s aforementioned 2011 Decadal Survey on 
Biological and Physical Sciences.  
“Given the typical lifespan of humans, 180 days in space may seem trivial. However, in 
the case of rodents, the animal model most scientists have used to study fundamental 
biological processes in space, such a time frame represents approximately one-fourth to one-
third of the species’ adult life. Thus, studies on these rodents in space have the potential to 
extrapolate important implications for humans living in space well beyond 6 months” 
(National Research Council Decadal Survey, 2011). 
 
Human ovaries are also about six times more resistant to radiation than 
mice, possibly due to relative oocyte population or cell-specific sensitivity, requiring 
a dose of 600 rads delivered over a few hours to induce permanent sterility (Lindop, 
1969). 
The ultimate goal of this study was to determine the involvement of varying 
levels of whole-body irradiation on ovarian luteal and follicular development in 
mice. It hopes to provide sufficient data for an anatomical comparison with mice of 
actual spaceflight. It is hypothesized that the increased exposure to cosmic radiation 
observed in spaceflight, or some combination of both microgravity and radiation, is 
to blame for structural and functional differences between spaceflight and ground 
control tissues. This opposes the idea that microgravity, or another outside factor 
(such as closed life support systems as Santy et al. 1990 suggests) is solely 
responsible for the observed results. 
Some of the mice in this experiment have been treated with apocynin, a drug 
that inhibits nicotinamide adenine dinucleotide phosphate-oxidase, often 
abbreviated “NADPH-oxidase” or simply “nox”. NADPH-oxidase plays a role in 
radiation-induced oxidative stress by converting molecular oxygen (O2) to 
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superoxide anions (O2-). Specifically, NADPH-oxidase has been shown to cause 
radiation-mediated upregulation of intracellular reactive oxygen species, or ROS. 
Therefore, the inhibition of NADPH-oxidase by apocynin should reduce radiation 
induced oxidative stress in tissues (Shatwell et al., 1996).  
Genetic knockouts were also used in this experiment, and are invaluable to in 
vivo case studies. Cells of NADPH-oxidase knockouts are unable to manufacture the 
enzyme, producing similar effects as treatment with apocynin, theoretically. The 
two most popular methods of generating knockouts are 1, germline knockout, which 
is full gene inactivation of the gene in all cells at all stages of development and 2, 
conditional mutagenesis, which enables cell-specific gene inactivation. (Friedel et al., 
2011). 
 
The Murine Estrous Cycle 
The murine estrous cycle is a cycle of hormonally-driven morphological 
changes in oocyte or follicular development and maturity within the ovary. Each of 
four phases (proestrous, estrous, metestrous, and diestrous) corresponds to a 
characteristic portion of the ovulatory timeline. During the proestrous phase of the 
estrous cycle, the growth of early-stage follicles, also known as preovulatory or 
Graafian follicles, begins. Deteriorating postovulatory cells, or corpora lutea, can 
also be seen. These atrophying lutea are marked by vacuolation within the cell 
(Westwood, 2008). Ovulation occurs during the estrous phase, which is marked by a 
higher concentration of late-stage follicles. These fluid-filled follicles are much 
larger, and rupture during ovulation, forming immature postovulatory or corpora 
lutea cells. During this roughly 24-hour period, fertilization may occur (Rugh and 
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Clugston, 1955). During the metestrous phase, recently-formed corpora lutea grow 
to their maximum size, vacuolizing during diestrous (Westwood, 2008). Parkes 
(1928) found the mean length of 1000 estrous cycles to be 6.213 days. Proestrous 
and estrous accounted for a mean of 2.494 days. Metestrous and diestrous 
accounted for a mean of 3.719 days.
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MATERIALS AND METHODS 
 
The tissues used in this study were provided by the laboratory of Dr. Michael 
Pecaut of Loma-Linda University in Loma-Linda, California. Thirty-six C57BL/6 mice 
were randomly split into two uniform groups of eighteen. One of these groups of eighteen 
was treated with apocynin, the other represented the wildtype control. A final group of 
eighteen  B6.129S6-Cybbtm1Din/J or “nox2 knockout” mice formed the third test 
group for a total of 54 mice.  
Within the knockout animals, the specific section of DNA responsible for 
coding for NADPH-oxidase2 has been inactivated or “knocked out”. A noncoding 
replacement section causes the resultant inhibited phenotype (Friedel et al., 2011). 
       Each of the three groups of eighteen were further divided into three 
subgroups of six, and given a label A-G. Three subgroups of six, one from each of the 
original groups of eighteen, were exposed to no whole-body radiation other than 
that which is incurred normally on Earth. A second set of three subgroups were 
exposed to 0.5 Gy whole-body radiation for an average of 0.94 minutes, and a third 
set were exposed to 2.0 Gy whole-body radiation for an average of 3.37 minutes. 
The resultant subgroups A-G appear in the chart below. 
SUBGROUP TREATMENT 
A WT Control 
B 0.5 Gy 
C 2 Gy 
D Apocynin (Apo) 
E Apo + 0.5 Gy 
F Apo + 2.0 Gy 
G NOX2 Knockout (KO) 
H KO + 0.5 Gy 
I KO + 2.0 Gy 
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       The mice in the experiment were irradiated via whole-body (excluding the 
head) proton radiation at Loma Linda University Medical Center Proton Treatment 
Facility. The animals did not receive anesthesia and were placed into identical 
rectangular enclosures and covered with a 400mm by 400mm polystyrene phantom 
prior to proton exposure. A Markers parallel plate ionization chamber from the 
National Institute of Standards and Technology was used to calibrate the proton 
dose. Water equivalent depth, or WED, is a measure of radiological thickness to 
which proton radiation techniques must be appropriately calibrated. A polystyrene 
phantom is a container used to calibrate WED.  
       After irradiation, the animals were euthanized at 8-9 weeks of age with one 
hundred percent carbon dioxide. Ovarian tissues were harvested by a lab technician 
within 30-60 minutes of sacrifice. After euthanasia, the specimen were fixed in four 
percent paraformaldehyde, and sent to the laboratory of Dr. Allan Forsman at East 
Tennessee State University, where the tissues were trimmed of fat and debris and 
stored in seventy percent ethanol solution. The ovaries, uterine horns, and uterine 
tubes were weighed independently before being dehydrated with increasing 
dilutions of ethanol, hemo-de, and paraplast in preparation for paraffin embedding. 
       Upon completion of the embedding process, one ovary from each animal was 
serially sectioned into 4 micrometer sections using a Micron HM35 microtome and 
mounted on glass microscope slides. These slides were stained according to 
standard H&E staining protocol.  
      After staining, the tissues were examined and photographed using a Zeiss 
Axioskop 4C compound microscope equipped with a Canon Powershot A640 digital 
camera. These photographs were used to formulate a comprehensive corpora luteal 
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and follicular count for each ovary. Follicles were determined to be of either late or 
early-stage development via the presence of a fluid-filled antrum. These counts 
were compared to total ovarian mass, total reproductive mass, and total body mass. 
Resultant ratios were compared with the apparent estrous phase. 
The phase of the estrous cycle for each animal was determined by an 
assessment of predominant cell type within corresponding vaginal smears. These 
smears were performed in the laboratory of Dr. Pecaut at the time of euthanasia. 
Proestrous was identified by the presence of nucleated epithelial cells. Estrous was 
identified by the predominance of cornified squamous epithelial cells. Metestrous 
was characterized by a mixture of leukocytes, nucleated epithelial, and cornified 
squamous epithelial cells. Diestrous contains almost solely leukocytes.  
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RESULTS 
 
 The mean ovarian and total reproductive weight of each treatment group can be 
seen in Table 1. These values are representative of recorded ovarian and total 
reproductive weights for control tissues, 0.5 Gy irradiated tissues, and 2.0 Gy irradiated 
tissues shown in full in Tables 7, 8, and 9. Measurements of total reproductive weight 
included ovarian, uterine, and vaginal tissues (Figure 1). Measurements of ovarian weight 
were inclusive of both ovaries when possible. An ovary was found to be absent from the 
F2 animal, reflected in both the individual and mean ovarian and total reproductive 
weights. Table 1 also features the z-score of the ovarian and total reproductive weights 
for all treatment groups. The between-group standard deviation of ovarian weight for all 
treatment groups was 0.437 mg. The between-group standard deviation of total 
reproductive weight for all treatment groups is 26.81 mg. This value, and the z-score are 
the result of a standard T-test, and are to be used in a discussion of significance within the 
data set. 
  
Mean Ovarian and Total Reproductive Weight, All Treatment Groups 
Treatment 
Group 
Ovarian 
Wt. 
(mg) 
Ovarian 
Wt.  
Z-Score 
Total 
Reproductive Wt. 
(mg) 
Total  
Reproductive Wt.  
Z-Score 
WT Control (A) 2.8 0.917 60.9 0.552 
0.5 Gy (B) 2.5 1.601 64.2 0.429 
2.0 Gy (C) 3.4 0.457 61.3 0.537 
Apocynin (D) 3.2 0.000 96.4 0.772 
Apo + 0.5 Gy (E) 3.5 0.686 72.8 0.108 
Apo + 2.0 Gy (F) 2.8 0.917 61.1 0.545 
NOX2 Knockout (G)  3.5 0.686 112.2 1.361 
KO + 0.5 Gy (H) 3.9 1.601 116.4 1.518 
KO + 2.0 Gy (I) 3.1 0.229 36.3 1.470 
Table 1: Mean Ovarian and Total Reproductive Weights for All Treatment Groups 
 Table 2 expresses the mean ovarian and total reproductive weights for each 
treatment group as percentages of total body weight. These values were obtained via 
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comparison of recorded ovarian and total reproductive weights (Tables 7, 8, and 9) with 
recorded total body weights (Table 10, 11, 12). The ovarian and total reproductive 
percent of total body weight for all animals can be found in Tables 13, 14, and 15. Table 
2 also lists the respective z-scores of ovarian and total reproductive percentages. 
Between-group standard deviation for ovarian percentage of total body weight  
2.36 × 10-5% for all treatment groups. Between-group standard deviation for total 
reproductive percentage of total body weight was 1.4 × 10-3 % for all treatment groups. 
Mean Ovarian Percent and Total Reproductive Percent of Total Body Weight, All 
Treatment Groups 
Treatment 
Group 
Ovarian 
Wt.  
(%) 
Ovarian Wt. 
%  
Z-Score 
Total Reproductive 
Wt.  
(%) 
Total Reproductive 
Wt. %  
Z-Score 
WT Control (A) 1.70 × 10-4 
 
0.424 3.6 × 10-3 0.429 
0.5 Gy (B) 1.44 × 10-4 1.525 3.7 × 10-3 0.357 
2.0 Gy (C) 2.08 × 10-4 1.186 3.7 × 10-3 0.357 
Apocynin (D) 1.84 × 10-4 0.170 5.6 × 10-3 1.000 
Apo + 0.5 Gy 
(E) 
1.96 × 10-4 0.678 4.0 × 10-3 0.143 
Apo + 2.0 Gy 
(F) 
1.53 × 10-4 1.144 3.3 × 10-3 0.643 
NOX2 
Knockout (G)  
2.08 × 10-4 1.186 5.8 × 10-3 1.143 
KO + 0.5 Gy (H) 2.15 × 10-4 1.483 6.3 × 10-3 1.500 
KO + 2.0 Gy (I) 1.74 × 10-4 0.254 1.9 × 10-3 1.643 
Table 2: Mean Ovarian and Total Reproductive Percent of Total Body Weight for All 
Treatment Groups. 
 
Early-stage ovarian follicular count means for each treatment group can be found 
in Table 3, along with z-scores. The between-group standard deviation of early-stage 
follicles for all treatment groups was 19.94. Individual recordings for control, 0.5 Gy 
irradiated, and 2.0 Gy irradiated animals are shown in Tables 16, 17, and 18. A 
representation of an early-stage follicle is pictured in Figure 2. 
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Mean Early-Stage Follicle Count, All Treatment Groups 
Treatment Group Early-Stage Follicles Early-Stage Follicles Z-Score 
WT Control (A) 197 2.021 
0.5 Gy (B) 140 0.838 
2.0 Gy (C) 162.7 0.301 
Apocynin (D) 167 0.517 
Apo + 0.5 Gy (E) 146.7 0.502 
Apo + 2.0 Gy (F) 159.3 0.130 
NOX2 Knockout (G)  163 0.316 
KO + 0.5 Gy (H) 126.3 1.525 
KO + 2.0 Gy (I) 148.7 0.401 
Table 3: Mean Early-Stage Follicle Counts for All Treatment Groups 
 Late-stage ovarian follicular count means for each treatment group can be found 
in Table 4 below, along with z-scores. The between-group standard deviation of late-
stage follicles for all treatment groups was 10.42. Individual recordings for control, 0.5 
Gy irradiated, and 2.0 Gy irradiated animals are shown in Tables 16, 17, and 18. A 
representation of a late-stage follicle is pictured in Figure 3. 
Mean Late-Stage Follicle Count, All Treatment Groups 
Treatment Group Late-Stage Follicles Late-Stage Follicles Z-Score 
WT Control (A) 18.7 1.056 
0.5 Gy (B) 17.3 1.190 
2.0 Gy (C) 30.0 0.029 
Apocynin (D) 35.3 0.537 
Apo + 0.5 Gy (E) 43.3 1.305 
Apo + 2.0 Gy (F) 47.0 1.660 
NOX2 Knockout (G)  26.7 0.288 
KO + 0.5 Gy (H) 27.3 0.230 
KO + 2.0 Gy (I) 21.7 0.786 
Table 4: Mean Late-Stage Follicle Counts for All Treatment Groups 
 Mean corpus luteum counts for each treatment group were recorded in Table 4 
below, along with z-scores. Individual recordings for control, 0.5 Gy, and 2.0 Gy 
irradiated animals are shown in Tables 19, 20, and 21. A representation of a corpus 
luteum is pictured in Figure 4. 
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Mean Corpus Luteum Counts, All Treatment Groups 
Treatment Group Corpus Luteum Corpus Luteum Z-Score 
WT Control (A) 3.7 0.111 
0.5 Gy (B) 5 0.611 
2.0 Gy (C) 7 1.722 
Apocynin (D) 4.3 0.222 
Apo + 0.5 Gy (E) 2.7 0.667 
Apo + 2.0 Gy (F) 1.3 1.444 
NOX2 Knockout (G)  4 0.056 
KO + 0.5 Gy (H) 5.3 0.778 
KO + 2.0 Gy (I) 1.7 1.222 
      Table 5: Mean Corpus Luteum Counts for All Treatment Groups 
 Estrous phase determinations made from vaginal smears of each animal are listed 
in Tables 21, 22, and 23. These determinations were used to structure Table 6, which 
depicts the number of ovaries within each treatment group that presented in each of the 
estrous phases. Representations of proestrous, estrous, metestrous, and diestrous smears 
may be found in Figures 5, 6, 7, and 8. 
Within-Group Estrous Phase Determination Totals, All Treatment Groups 
Treatment Group Proestrous Estrous Metestrous Diestrous 
WT Control (A) 0 0 1 2 
0.5 Gy (B) 0 1 0 2 
2.0 Gy (C) 1 1 0 1 
Apocynin (D) 0 2 1 0 
Apo + 0.5 Gy (E) 0 2 0 1 
Apo + 2.0 Gy (F) 0 1 1 1 
NOX2 Knockout (G)  0 3 0 0 
KO + 0.5 Gy (H) 0 2 0 1 
KO + 2.0 Gy (I) 0 1 0 2 
TOTAL 1 13 3 10 
Table 6: Within-Group Estrous Phase Determination Totals for All Treatment Groups 
 Statistical significance was observed for z-scores greater than 1.645, 
corresponding to p-values of 0.05, or 95% confidence that the null hypothesis is false. In 
other words, the hypothesis that radiation has no significant effect on ovarian 
morphology is false. Representative ovarian sections from Treatment Group’s A-I are 
pictured in Figures 9-17.
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DISCUSSION 
In regard to ovarian weight, the results of Table 1 (Mean Ovarian and Total 
Reproductive Weights for All Treatment Groups) reveal two points of interest: a minima 
in Treatment Group B (WT + 0.5 Gy) of 2.5 mg, and a maxima in Treatment Group H 
(KO + 0.5 Gy) of 3.9 mg. Compared to a between-group standard deviation of 0.437, 
both groups are well beyond one standard deviation and worth mention. However, with z-
scores of only 1.601, these values are not statistically significant and may be explained by 
natural variation. It may be concluded from analyzing the result of the T-test that there is 
no significant correlation between ovarian weight and irradiation up to 2.0 Gy. 
Table 1 also highlights Treatment Groups G (KO + 0.0 Gy) and H (KO + 0.5 Gy) 
for their high total reproductive weight. Treatment Group G has a mean total reproductive 
weight of 112.2 mg, much higher than one standard deviation (26.81) above the grand 
mean of 75.7 mg. Treatment Group H has a mean total reproductive weight of 116.4 mg, 
nearly two standard deviations above the grand mean. However, with z-scores of 1.361 
and 1.518, respectively, neither result is statistically significant and may be explained by 
natural variation. From the analyzing result of the T-test, it may be concluded that total 
reproductive weight is not significantly affected by irradiation up to 2.0 Gy. 
The results in Table 2 depict a minimum mean ovarian weight percentage in 
Treatment Group B (WT + 0.5 Gy) of 1.44 × 10-4%, much lower than one standard 
deviation (2.36 × 10-5). Also shown is a maximum mean ovarian weight percentage in 
Treatment Group H (KO + 0.5 Gy) of 2.15 × 10-4%, much higher than one standard 
deviation of 2.36 × 10-5 from the grand mean of 1.80 × 10-4%. However, with z-scores 
of 1.5254 and 1.4831, respectively, these endpoints of the range escape statistical 
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significance. From the result of the T-test, it may be concluded that radiation has no 
significant influence on the ovarian weight to total body weight ratio. 
Table 2 also highlights a maxima in Treatment Group I (KO + 2.0 Gy), where the 
mean total reproductive weight percentage of total body weight was 1.9 × 10-3%. This 
value is nearly two standard deviations (1.4 × 10-3) lower than the grand mean of 4.2 × 
10-3%. However, with a z-score of 1.6429, it is not statistically significant. This suggests 
there is no correlation between radiation and the total reproductive weight to total body 
weight ratio. 
Statistical analysis of the results in Table 3 (Mean Early-Stage Follicle Counts for 
All Treatment Groups) show that with an average early-stage follicle count of 197, and a 
z-score of 2.021, Treatment Group A (WT + 0.0 Gy) has a significantly high count. This 
result suggests that amongst the wildtype treatment group, normal or Earth-provided 
radiation does not inhibit early-stage follicular development. Treatment Group H (KO + 
0.5 Gy) provides the minima for this data set at a mean of 126.3 early-stage follicles, 
more than one standard deviation (19.94) below the grand mean of 156.7 early-stage 
follicles. This result is surprising, given that Treatment Group H has the highest ovarian 
and total reproductive weights of the data set. However, with a z-score of 1.525, 
Treatment Group H is not statistically significant and may be explained by normal 
variation. 
Table 4 (Mean Late-Stage Follicle Counts for All Treatment Groups) illustrates 
an interesting trend within the apocynin-treated group. Within this group, late-stage 
follicular count increased from a mean of 35.5 to 47.0 as radiation increased from 0.0 to 
2.0 Gy. This result culminates with Treatment Group F (Apo + 2.0 Gy), with a 
significantly high late-stage follicular count mean of 47.0 follicles, nearly two standard 
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deviations (10.42) above the grand mean of 29.7 follicles. As shown, the z-score for 
Treatment Group F was 1.660. Strangely, the same trend also exists within the wildtype 
and knockout groups if one accounts for how the lower than average ovarian weights of 
Treatment Groups B (WT + 0.5 Gy) and I (KO + 2.0 Gy) may have limited follicular 
count. But, however interesting, no wildtype or knockout treatment group is host to 
significantly high or low late-stage follicular counts. This result suggests that radiation 
level may have a slight excitatory effect on late-stage follicular development, or an 
inhibitory effect on ovulation, leading to a greater late-stage follicular density. 
The results in Table 5 (Mean Corpus Luteum Counts for All Treatment Groups) 
are also interesting. Within the wildtype treatment group, the appearance of corpora lutea 
increases from means of 3.7-7.0 as radiation increases from 0.0 to 2.0 Gy, culminating in 
significantly high corpora lutea in Treatment Group C (WT + 2.0 Gy). This trend is not 
seen in the knockout treatment group, and a slight opposite trend is seen in the apocynin-
treated group, both of which are NADPH-oxidase inhibited. This result suggests that 
radiation up to 2.0 Gy significantly increases corpora luteal concentration within the 
ovary. As pointed out earlier, this effect could be explained by an acceleration of oocyte 
development, as suggested by Peters (1961) and Oakberg (1962). An increase in corpora 
luteal count after radiation also illustrates that radiation of 2.0 Gy or higher does not 
inhibit ovulation. This is because the corpus luteum itself forms as a result of ovulation. 
The trend is not present in the NADPH-oxidase inhibited groups, suggesting that the 
ability to ameliorate the effects of radiation is preventing this process in all groups other 
than the untreated wildtype. 
Table 6 displays estrous phase characterization for each treatment group. To 
understand the effect of estrous phase on an interpretation of the results, the properties of 
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each phase must be reexamined. For example, ovary C1 from Table 24 is in the 
proestrous phase. Theoretically, within the same treatment group, most proestrous ovaries 
will have lower numbers of late-stage follicles than their estrous and diestrous 
counterparts. The absence of these large, late-stage follicles and mature corpora lutea also 
contributes to lower luteal counts and smaller organ size. Indeed, C1 has a late-stage 
follicular count of 23 and a corpora luteal count of 6, the lowest of any ovary in its 
treatment group. However, at an ovarian weight of 3.6 mg and ovarian percentage of total 
body mass of 2.27 × 10-4%, C1 is the largest ovary in its group. Although this last result 
seems contrary to the properties of the proestrous phase, it must be considered that the C1 
animal also had the largest total reproductive weight at 88.9, almost twice that of C2 and 
C3. This easily explains the discrepancy and is a good example of natural variation. 
Likewise, mice from Treatment Groups D, E, G, and H that have a high-estrous 
characterization (2 or more ovaries within the group are of the estrous phase) would be 
expected to have larger ovaries and higher late-stage follicular counts than Treatment 
Groups A, B, and I (their high-diestrous-characterized counterparts) Indeed, this is the 
case across the board for both late-stage follicular count and ovarian weight to total body 
weight ratio. Groups D, E, G, and H have mean late-stage counts of 35.3, 43.3, 26.7, and 
27.3, respectively. These results are much higher than the late-stage means from groups 
A (18.7), B (17.3), and I (21.7). The same trend is seen in ovarian size. The ovaries from 
groups D, E, G, and H were much larger at 1.84 × 10-4%, 1.96 × 10-4%, 1.79 × 10-4%, 
and 2.15 × 10-4% of total body mass, respectively.  
The results of this study are somewhat corroborated by findings in previous 
studies on the effect of radiation on follicular development. Radiation studies by Peters 
(1961) and Oakberg (1962) noted an acceleration of oocyte maturation after exposure to 
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low-dose irradiation. This finding would explain trends toward increasing late-stage 
follicular count and corpora lutea count in wildtype mice, but fails to explain why this 
effect was not ameliorated in the late-stage follicles of apocynin-treated mice. Peters and 
Oakberg also noted radiation-induced cell depletion in mice 2 ½ weeks old and younger 
was ameliorated by the adaptive mechanism of decreased natural oocyte depletion. 
Because the mice of this study were 8 to 9 weeks of age at euthanasia, this effect would 
not be seen in any of the treatment groups. The hypothesis that increased exposure to 
radiation, also seen in spaceflight, may have a significant structural effect upon ovarian 
follicular development is supported by the data of this study. 
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CONCLUSIONS 
Without accounting for morphological differences resulting from estrous phase 
variation within each group, radiation from 0.5 to 2.0 Gy had no significant effect on 
mean ovarian weight, mean total reproductive weight, mean ovarian percent of total body 
weight, and mean total reproductive percent of total body weight in any treatment group. 
However, radiation of 0.5 Gy or higher did significantly decrease mean early-stage 
follicular count in the wildtype mice, an effect that did not present in the apocynin-treated 
or knockout groups. Radiation of 2.0 Gy or higher also increased mean late-stage 
follicular count across all treatments, significantly increasing the late-stage count in 
apocynin-treated mice. Although, as discussed, a significant increase due to 2.0 Gy 
radiation is found in all treatments if ovarian percent of total body weight is taken into 
account. Finally, radiation of 2.0 Gy or higher significantly increased mean corpora lutea 
count in wildtype mice, but not in apocyin-treated or knockout mice. This suggests that 
treatment with apocynin or genetic knockout of the NADPH-oxidase coding region may 
ameliorate early-stage decrease and luteal count increase in mice exposed to radiation.  
Because the phase of the estrous cycle was not the same for all animals, and 
varied both within and between each treatment group, any determination of trend or 
significance between data sets may only be viewed out of the context of estrous phase. 
This places a severe limitation on the data, and contributes to a decrease in the n value for 
the data set. Essentially, treatment groups like F, which contain one estrous, one 
metestrous, and one diestrous ovary see a decrease from n=3 to n=1 for the group. This n 
value is much too low for counts to be of statistical value. In-depth studies on the effect 
of radiation on ovarian morphology are required. These should examine either ovaries of 
a single phase only or conduct an experiment of such magnitude (high n value) that phase 
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is irrelevant.
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FIGURES AND TABLES 
 
 
Figure 1: Two total reproductive tracts, including ovarian, uterine, and vaginal 
tissues. These animals also were part of the same treatment group, illustrating a 
remarkable range of natural variation. 
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Figure 2: Early-stage follicles within an ovarian section (100X). Arrows indicate 
representative structures. Green Arrows = Early-Stage Follicles, Blue Arrows = Late-
Stage Follicles (antrum present)  
 
 
Figure 3: Late-stage follicles within an ovarian section. Arrows indicate 
representative structures (200X). Blue Arrows = Late-Stage Follicles (antrum 
present), Black Arrows = Corpora Lutea 
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Figure 4: Corpora luteum within an ovarian section (100X). Arrows indicate 
representative structures. Green Arrows = Early-Stage Follicles, Blue Arrows = Late-
Stage Follicles (antrum present), Black Arrows = Corpora Lutea 
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Figure 5: Proestrous phase vaginal smear from C1 animal (200X). 
 
 
Figure 6: Estrous phase vaginal smear from E3 animal (200X). 
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Figure 7: Metestrous phase vaginal smear from D3 animal (200X). 
 
 
Figure 8: Diestrous phase vaginal smear from D5 animal (400X). 
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Figure 9: Ovarian section from Treatment Group A (WT + 0.0 Gy), showing early-
stage and late-stage follicles (100X). 
 
 
Figure 10: Ovarian section from Treatment Group B (WT + 0.5 Gy), showing early-
stage follicles, late-stage follicles, and corpora lutea (100X). 
 
 Poole 42 
 
Figure 11: Ovarian section from Treatment Group C (WT + 2.0 Gy), showing early-
stage follicles, late-stage follicles, and corpora lutea (100X). 
 
 
Figure 12: Ovarian section from Treatment Group D (Apo + 0.0 Gy), showing early-
stage follicles, late-stage follicles, and corpora lutea (100X). 
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Figure 13: Ovarian section from Treatment Group E (Apo + 0.5 Gy), showing early-
stage follicles, late-stage follicles, and corpora lutea (100X). 
 
 
Figure 14: Ovarian section from Treatment Group F (Apo + 2.0 Gy), showing early-
stage follicles, late-stage follicles, and corpora lutea (100X). 
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Figure 15: Ovarian section from Treatment Group G (KO + 0.0 Gy), showing early-
stage follicles, late-stage follicles, and corpora lutea (100X). 
 
 
Figure 16: Ovarian section from Treatment Group H (KO + 0.5 Gy), showing early-
stage follicles, late-stage follicles, and corpora lutea (50X). 
 Poole 45 
 
Figure 17: Ovarian section from Treatment Group I (KO + 2.0 Gy), showing early-
stage follicles and late-stage follicles (100X). 
Wildtype Tissues (uncolored)                                                                                                                                
Apocynin-Treated Tissues                                                                                                                           
Knockout Tissues           
 
Ovarian, Uterine Tube, and Composite Reproductive Weight, Control Tissues 
Specimen Ovarian Wt. 
(mg) 
Uterine Tube Wt. 
(mg) 
Total Reproductive Wt. 
(mg) 
A2 3.1 3.6 105.9 
A3 2.0 2.2 26.1 
A4 3.3 2.5 50.6 
D1 2.7 2.8 98.1 
D2 3.2 2.0 75.6 
D4 3.6 3.5 115.4 
G1 3.5 1.8 68.1 
G2 3.8 3.5 159.9 
G3 3.1 2.6 108.7 
Table 7: Ovarian, Uterine Tube, and Composite Reproductive Weight for Control Tissues 
(0 Gy) 
 
Ovarian, Uterine Tube, and Composite Reproductive Weight, 0.5 Gy Tissues 
Specimen Ovarian Wt. 
(mg) 
Uterine Tube Wt. 
(mg) 
Total Reproductive Wt. 
(mg) 
B1 2.6 1.7 84.1 
B2 2.9 2.8 50.1 
B3 2.1 2.9 58.4 
E1 3.3 2.1 57.6 
E2 3.3 3.2 102.2 
E3 3.9 2.3 58.7 
H1 3.0 2.3 138.5 
H2 4.3 2.8 132.9 
H3 4.5 2.7 77.9 
Table 8: Ovarian, Uterine Tube, and Composite Reproductive Weight for 0.5 Gy 
Irradiated Tissues 
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Ovarian, Uterine Tube, and Composite Reproductive Weight, 2.0 Gy Tissues 
Specimen Ovarian Wt. 
(mg) 
Uterine Tube Wt. 
(mg) 
Total Reproductive Wt. 
(mg) 
C1 3.6 2.1 88.9 
C2 3.2 1.7 52.6 
C3 3.5 1.6 42.5 
F1 3.1 2.6 97.0 
F2 1.5 2.1 52.0 
F3 3.8 1.8 34.3 
I1 1.5 2.0 40.9 
I2 4.1 2.6 42.6 
I4 3.8 0.7 25.5 
Table 9: Ovarian, Uterine Tube, and Composite Reproductive Weight for 2.0 Gy 
Irradiated Tissues 
 
Total Body Weight, Control Tissues 
Specimen Total Body Weight (mg) 
A2 17,490 
A3 14,460 
A4 16,920 
D1 16,940 
D2 17,250 
D4 17,340 
G1 18,990 
G2 20,500 
G3 18,430 
Table 10: Total Body Weight for Control Tissues 
 
Total Body Weight, Control Tissues 
Specimen Total Body Weight (mg) 
B1 16,970 
B2 19,010 
B3 16,640 
E1 18,900 
E2 18,430 
E3 16,650 
H1 18,820 
H2 18,690 
H3 17,600 
Table 11: Total Body Weight for 0.5 Gy Irradiated Tissues 
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Total Body Weight, Control Tissues 
Specimen Total Body Weight (mg) 
C1 15,850 
C2 17,390 
C3 16,540 
F1 18,810 
F2 17,750 
F3 18,090 
I1 21,090 
I2 17,900 
I4 17,180 
Table 12: Total Body Weight for 2.0 Gy Irradiated Tissues 
 
Ovarian Percent and Total Reproductive Percent of Total Body Weight, Control Tissues 
Specimen Ovarian Wt. (%) Total Reproductive Wt. (%) 
A2 1.77 × 10-4 6.1 × 10-3 
A3 1.38 × 10-4 1.8 × 10-3 
A4 1.95 × 10-4 3.0 × 10-3 
D1 1.59 × 10-4 5.8 × 10-3 
D2 1.86 × 10-4 4.4 × 10-3 
D4 2.08 × 10-4 6.7 × 10-3 
G1 1.84 × 10-4 3.6 × 10-3 
G2 1.85 × 10-4 7.8 × 10-3 
G3 1.68 × 10-4 5.9 × 10-3 
Table 13: Ovarian Percent and Total Reproductive Percent of Total Body Weight for 
Control Tissues 
 
Ovarian Percent and Total Reproductive Percent of Total Body Weight, 0.5 Gy Tissues 
Specimen Ovarian Wt. (%) Total Reproductive Wt. (%) 
B1 1.53 × 10-4 5.0 × 10-3 
B2 1.53 × 10-4 2.6 × 10-3 
B3 1.26 × 10-4 3.5 × 10-3 
E1 1.75 × 10-4 3.0 × 10-3 
E2 1.79 × 10-4 5.5 × 10-3 
E3 2.34 × 10-4 3.5 × 10-3 
H1 1.59 × 10-4 7.3 × 10-3 
H2 2.30 × 10-4 7.1 × 10-3 
H3 2.56 × 10-4 4.4 × 10-3 
Table 14: Ovarian Percent and Total Reproductive Percent of Total Body Weight for 0.5 
Gy Irradiated Tissues 
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Ovarian Percent and Total Reproductive Percent of Total Body Weight, 2.0 Gy Tissues 
Specimen Ovarian Wt. (%) Total Reproductive Wt. (%) 
C1 2.27 × 10-4 5.6 × 10-3 
C2 1.84 × 10-4 3.0 × 10-3 
C3 2.12 × 10-4 2.6 × 10-3 
F1 1.65 × 10-4 5.2 × 10-3 
F2 8.45 × 10-5 2.9 × 10-3 
F3 2.10 × 10-4 1.9 × 10-3 
I1 7.11 × 10-5 1.9 × 10-3 
I2 2.29 × 10-4 2.4 × 10-3 
I4 2.21 × 10-4 1.5 × 10-3 
Table 15: Ovarian Percent and Total Reproductive Percent of Total Body Weight for 2.0 
Gy Irradiated Tissues 
 
Early and Late-Stage Follicular Counts, Control Tissues 
Specimen Early-Stage Follicles Late-Stage Follicles 
A2 181 33 
A3 234 9 
A4 174 14 
D1 157 35 
D2 153 34 
D4 191 37 
G1 144 19 
G2 178 31 
G3 167 30 
Table 16: Early and Late-Stage Follicular Counts for Control Tissues (0 Gy) 
 
Early and Late-Stage Follicular Counts, 0.5 Gy Tissues 
Specimen Early-Stage Follicles Late-Stage Follicles 
B1 112 29 
B2 191 15 
B3 117 8 
E1 71 58 
E2 238 46 
E3 131 26 
H1 150 18 
H2 154 20 
H3 75 44 
Table 17: Early and Late-Stage Follicular Counts for 0.5 Gy Irradiated Tissues 
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Early and Late-Stage Follicular Counts, 2.0 Gy Tissues 
Specimen Early-Stage Follicles Late-Stage Follicles 
C1 103 23 
C2 201 37 
C3 184 30 
F1 197 74 
F2 152 39 
F3 129 28 
I1 167 18 
I2 175 15 
I4 104 32 
Table 18: Early and Late-Stage Follicular Counts for 2.0 Gy Irradiated Tissues 
 
Luteal Counts, Control Tissues 
Specimen Corpora Lutea 
A2 6 
A3 1 
A4 4 
D1 5 
D2 3 
D4 5 
G1 4 
G2 5 
G3 3 
Table 19: Luteal Counts for Control Tissues (0 Gy) 
 
Luteal Counts, 0.5 Gy Tissues 
Specimen Corpora Lutea 
B1 6 
B2 4 
B3 5 
E1 1 
E2 3 
E3 4 
H1 8 
H2 3 
H3 5 
Table 20: Luteal Counts for 0.5 Gy Irradiated Tissues 
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Luteal Counts, 2.0 Gy Tissues 
Specimen Corpora Lutea 
C1 6 
C2 7 
C3 8 
F1 2 
F2 0 
F3 2 
I1 3 
I2 2 
I4 0 
Table 21: Luteal Counts for 2.0 Gy Irradiated Tissues 
 
Estrous Phase Determination, Control Tissues 
Specimen Phase Determination 
A2 Diestrous 
A3 Metestrous 
A4 Diestrous 
D1 Estrous 
D2 Metestrous 
D4 Estrous 
G1 Estrous 
G2 Estrous 
G3 Estrous 
Table 22: Estrous Phase Determinations for Control Tissues (0 Gy) 
 
Estrous Phase Determination, 0.5 Gy Tissues 
Specimen Phase Determination 
B1 Diestrous 
B2 Diestrous 
B3 Estrous 
E1 Diestrous 
E2 Estrous 
E3 Estrous 
H1 Estrous 
H2 Estrous 
H3 Diestrous 
Table 23: Estrous Phase Determinations for 0.5 Gy Irradiated Tissues 
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Estrous Phase Determination, 2.0 Gy Tissues 
Specimen Phase Determination 
C1 Proestrous 
C2 Diestrous 
C3 Estrous 
F1 Metestrous 
F2 Estrous 
F3 Diestrous 
I1 Diestrous 
I2 Estrous 
I4 Diestrous 
Table 24: Estrous Phase Determinations for 2.0 Gy Irradiated Tissues 
 
